Sub-Perception and Supra-Perception Spinal Cord Stimulation in Chronic Pain Syndrome: A Randomized, Semi-Double-Blind, Crossover, Placebo-Controlled Trial.
complex regional pain syndrome
cross-over trial
failed back surgery syndrome
placebo control
spinal cord stimulation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
31 Aug 2020
31 Aug 2020
Historique:
received:
11
07
2020
revised:
18
08
2020
accepted:
29
08
2020
entrez:
4
9
2020
pubmed:
4
9
2020
medline:
4
9
2020
Statut:
epublish
Résumé
The introduction of modern sub-perception modalities has improved the efficacy of spinal cord stimulation (SCS) in refractory pain syndromes of the trunk and lower limbs. The objective of this study was to evaluate the effectiveness of low and high frequency SCS among patients with chronic pain. A randomised, semi-double-blind, placebo controlled, four period (4 × 2 weeks) crossover trial was conducted from August 2018 to January 2020. Eighteen patients with SCS due to failed back surgery syndrome and/or complex regional pain syndrome were randomised to four treatment arms without washout periods: (1) low frequency (40-60 Hz), (2) 1 kHz, (3) clustered tonic, and (4) sham SCS (i.e., placebo). The primary outcome was pain scores measured by visual analogue scale (VAS) preoperatively and during subsequent treatment arms. Pain scores (VAS) reported during the preoperative period was M (SD) = 8.13 (0.99). There was a 50% reduction in pain reported in the low frequency tonic treatment group (M (SD) = 4.18 (1.76)), a 37% reduction in the 1 kHz treatment group (M (SD) = 5.17 (1.4)), a 34% reduction in the clustered tonic settings group (M (SD) = 5.27 (1.33)), and a 34% reduction in the sham stimulation group (M (SD) = 5.42 (1.22)). The reduction in pain from the preoperative period to the treatment period was significant in each treatment group ( The pain-relieving effects of SCS reached significance and were comparable across all modes of stimulation including sham. Sub-perception stimulation was not superior to supra-perception. SCS was characterised by a high degree of placebo effect. No evidence of carryover effect was observed between subsequent treatments. Contemporary neuromodulation procedures should be tailored to the individual preferences of patients.
Sections du résumé
BACKGROUND
BACKGROUND
The introduction of modern sub-perception modalities has improved the efficacy of spinal cord stimulation (SCS) in refractory pain syndromes of the trunk and lower limbs. The objective of this study was to evaluate the effectiveness of low and high frequency SCS among patients with chronic pain.
MATERIAL AND METHODS
METHODS
A randomised, semi-double-blind, placebo controlled, four period (4 × 2 weeks) crossover trial was conducted from August 2018 to January 2020. Eighteen patients with SCS due to failed back surgery syndrome and/or complex regional pain syndrome were randomised to four treatment arms without washout periods: (1) low frequency (40-60 Hz), (2) 1 kHz, (3) clustered tonic, and (4) sham SCS (i.e., placebo). The primary outcome was pain scores measured by visual analogue scale (VAS) preoperatively and during subsequent treatment arms.
RESULTS
RESULTS
Pain scores (VAS) reported during the preoperative period was M (SD) = 8.13 (0.99). There was a 50% reduction in pain reported in the low frequency tonic treatment group (M (SD) = 4.18 (1.76)), a 37% reduction in the 1 kHz treatment group (M (SD) = 5.17 (1.4)), a 34% reduction in the clustered tonic settings group (M (SD) = 5.27 (1.33)), and a 34% reduction in the sham stimulation group (M (SD) = 5.42 (1.22)). The reduction in pain from the preoperative period to the treatment period was significant in each treatment group (
CONCLUSIONS
CONCLUSIONS
The pain-relieving effects of SCS reached significance and were comparable across all modes of stimulation including sham. Sub-perception stimulation was not superior to supra-perception. SCS was characterised by a high degree of placebo effect. No evidence of carryover effect was observed between subsequent treatments. Contemporary neuromodulation procedures should be tailored to the individual preferences of patients.
Identifiants
pubmed: 32878061
pii: jcm9092810
doi: 10.3390/jcm9092810
pmc: PMC7563558
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Paweł Sokal reports non-financial support from Medtronic and Boston Scientific. Agnieszka Malukiewicz and Marcin Rudaś report non-financial support from Boston Scientfic. Sara Kierońska, Joanna Murawska, Cezary Guzowski, Marcin Rusinek, Dariusz Paczkowski, and Mateusz Krakowiak report no conflicts of interest.
Références
J Pain Symptom Manage. 2006 Apr;31(4 Suppl):S13-9
pubmed: 16647590
Neuromodulation. 2013 Jul-Aug;16(4):363-9; discussion 369
pubmed: 23425338
Pain Med. 2017 Aug 1;18(8):1534-1548
pubmed: 28108641
Eur J Pain. 2017 Mar;21(3):507-519
pubmed: 27714945
Pain Med. 2019 Jun 1;20(Suppl 1):S31-S40
pubmed: 31152175
Anesthesiology. 2015 Oct;123(4):851-60
pubmed: 26218762
Neuromodulation. 2014 Jul;17(5):443-50
pubmed: 24945621
Ir J Med Sci. 2017 Aug;186(3):767-771
pubmed: 28132158
Neuromodulation. 2018 Jul;21(5):457-465
pubmed: 29608229
Pain Med. 2019 Jul 1;20(7):1355-1361
pubmed: 30889248
Pain Med. 2016 Dec;17(12):2326-2336
pubmed: 28025366
World Neurosurg. 2013 Nov;80(5):642-649.e1
pubmed: 23321375
Neuromodulation. 2018 Jan;21(1):67-76
pubmed: 29220121
Pain. 2020 Jan;161(1):24-35
pubmed: 31453983
Qual Life Res. 2016 Jul;25(7):1771-7
pubmed: 26694963
Pain Med. 2019 Jun 1;20(Suppl 1):S47-S57
pubmed: 31152177
Neurosurgery. 2010 May;66(5):986-90
pubmed: 20404705
Neuromodulation. 2020 Jan;23(1):102-108
pubmed: 31265205
Neuromodulation. 2017 Oct;20(7):661-667
pubmed: 28544182
Neuromodulation. 2020 Jan;23(1):10-18
pubmed: 31305001
Eur J Pain. 2012 May;16(5):648-55
pubmed: 22337509
Neurosurgery. 2016 Nov;79(5):667-677
pubmed: 27584814
Neuromodulation. 2017 Oct;20(7):642-649
pubmed: 28834092
Pain Med. 2019 Jun 1;20(Suppl 1):S13-S22
pubmed: 31152180
Pain Pract. 2014 Jul;14(6):489-505
pubmed: 23834386
Neuromodulation. 2014 Aug;17(6):515-50; discussion 550
pubmed: 25112889
BMJ. 2019 Jul 31;366:l4378
pubmed: 31366597
Neuromodulation. 2018 Jan;21(1):56-66
pubmed: 28961366
Neuromodulation. 2020 Jul;23(5):653-659
pubmed: 31231912
J Pain Res. 2013 Aug 01;6:617-23
pubmed: 23946668
Curr Pain Headache Rep. 2019 Mar 14;23(4):25
pubmed: 30868285